ReviewCureus2024

The Role of Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Therapies in Early-Stage Breast Cancer: Current Practices, Treatment De-escalation, and Future Prospects.

Mohamed Hashem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.